Author:
Lu Justin Y.,Ho Scott L.,Buczek Alexandra,Fleysher Roman,Hou Wei,Chacko Kristina,Duong Tim Q.
Abstract
AbstractThis study investigated whether acute liver injury (ALI) persisted and identified predictors of ALI recovery [as indicated by alanine aminotransferase (ALT) level] at hospital discharge and 2 months post-discharge for 7595 hospitalized COVID-19 patients from the Montefiore Health System (03/11/2020–06/03/2021). Mild liver injury (mLI) was defined as ALT = 1.5–5 ULN, and severe livery injury (sLI) was ALT ≥ 5 ULN. Logistic regression was used to identify predictors of ALI onset and recovery. There were 4571 (60.2%), 2306 (30.4%), 718 (9.5%) patients with no liver injury (nLI), mLI and sLI, respectively. Males showed higher incidence of sLI and mLI (p < 0.05). Mortality odds ratio was 4.15 [95% CI 3.41, 5.05, p < 0.001] for sLI and 1.69 [95% CI 1.47, 1.96, p < 0.001] for mLI compared to nLI. The top predictors (ALT, lactate dehydrogenase, ferritin, lymphocytes) accurately predicted sLI onset up to three days prior. Only 33.5% of mLI and 17.1% of sLI patients (survivors) recovered completely at hospital discharge. Most ALI patients (76.7–82.4%) recovered completely ~ 2 months post-discharge. The top predictors accurately predicted recovery post discharge with 83.2 ± 2.2% accuracy. In conclusion, most COVID-19 patients with ALI recovered completely ~ 2 months post discharge. Early identification of patients at-risk of persistent ALI could help to prevent long-term liver complications.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733. https://doi.org/10.1056/NEJMoa2001017 (2020).
2. Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5 (2020).
3. Wu, J., Song, S., Cao, H. C. & Li, L. J. Liver diseases in COVID-19: Etiology, treatment and prognosis. World J. Gastroenterol. 26, 2286–2293. https://doi.org/10.3748/wjg.v26.i19.2286 (2020).
4. Del Zompo, F. et al. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: Systematic review with meta-analysis. Eur. Rev. Med. Pharmacol. Sci. 24, 13072–13088 (2020).
5. Amiri-Dashatan, N., Koushki, M., Ghorbani, F. & Naderi, N. Increased inflammatory markers correlate with liver damage and predict severe COVID-19: A systematic review and meta-analysis. Gastroenterol. Hepatol. Bed Bench 13, 282 (2020).